Vidu Garg, MD :: Nationwide Children’s Hospital, Columbus, Ohio

Vidu Garg, MD

Vidu Garg, MD

22q Center
Physician Team

Cardiology Fellowship
Faculty

Center for Cardiovascular Research
Director

Heart Center
Physician Team

Vidu Garg Lab
Principal Investigator

Contact Information

Cardiology
700 Children's Dr
Columbus, OH 43205 [ map ]
PH: (614) 722-2530
FX: (614) 722-2549
Email Me
The Research Institute at Nationwide Children's Hospital
700 Children's Drive
Columbus, Ohio 43205 [ map ]
PH: (614) 355-5710
FX: (614) 355-5725

Location Information for Patients

Main Campus

Biography

Vidu Garg, MD, is Director of Translational Research, The Heart Center and the Center for Cardiovascular Research at The Research Institute at Nationwide Children’s Hospital. Dr. Garg completed his pediatric residency at Nationwide Children’s Hospital in 1997 after which he spent five years at University of Texas Southwestern completing his pediatric cardiology training and a post-doctoral research fellowship in cardiac development and cardiovascular genetics. Subsequently, he joined the faculty at University of Texas Southwestern before returning to Nationwide Children’s. Dr. Garg’s research laboratory focuses on molecular pathways controlling cardiac development and the genetics of congenital heart disease. He is board certified in pediatrics.

View CV »

Gender:

  • Male

Languages Spoken:

  • English

Research Interests

Research Center:

Areas of Interest:

  • The laboratory focuses on understanding the genetic basis of congenital heart disease and the molecular pathways regulating normal and abnormal cardiac development. We have identified familial cases of congenital heart disease and used traditional linkage studies to discover novel genetic etiologies of human congenital cardiac malformations. In addition, we are interesting in understanding how these mutations disrupt normal cardiac development and are generating mouse models to gain insight into the molecular basis of congenital heart disease. Lab Web Site: http://www.nationwidechildrens.org/garg-lab

Education and Training

Undergraduate School

  • The Pennsylvania State University
    Date Completed: 06/30/1992

Medical School

  • Jefferson Medical College
    Date Completed: 06/10/1994

Residency

  • Nationwide Children's Hospital
    Date Completed: 06/30/1997

Fellowship

  • Children's Medical Center of Dallas
    Date Completed: 06/30/2000

Fellowship

  • University of Texas Southwestern Medical Center
    Date Completed: 06/30/2002

Department:

  • Pediatrics

Section:

  • Cardiology

Specialty:

  • Pediatric Cardiology

Date of Appointment at Nationwide Children’s Hospital:

  • 07/31/2009

Professional Experience

2009–present

  • Associate Professor, Department of Pediatrics, The Ohio State University, Columbus, Ohio

2009–present

  • Director of Translational Research, The Heart Center & Center for Cardiovascular Research, Nationwide Children’s Hospital, Columbus, Ohio

2009–present

  • Associate Professor, Department of Molecular Genetics, The Ohio State University

2005–2009

  • Assistant Professor, McDermott Center of Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, Texas

2005–2009

  • Assistant Professor, Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas

2002–2009

  • Assistant Professor, Department of Pediatrics, Division of Pediatric Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas

2000–2002

  • Assistant Instructor, Department of Pediatrics, Division of Pediatric Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas

1994–1997

  • Clinical Instructor, Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio

Publications

  • 2017. Genetic basis of aortic valvular disease.  Current Opinion in Cardiology.
  • 2016. Enhancing Literacy in Cardiovascular Genetics: A Scientific Statement From the American Heart Association.  CIRCULATION-CARDIOVASCULAR GENETICS. Vol. 9, no. 5. (October 1).
  • 2016. A genome-wide association study of congenital cardiovascular left-sided lesions shows association with a locus on chromosome 20.  HUMAN MOLECULAR GENETICS. Vol. 25, no. 11. (June 1).
  • 2016. Endothelial Notch1 Is Required for Proper Development of the Semilunar Valves and Cardiac Outflow Tract.  JOURNAL OF THE AMERICAN HEART ASSOCIATION. Vol. 5, no. 4. (April 1).
  • 2016. Measuring genetic knowledge: a brief survey instrument for adolescents and adults.  CLINICAL GENETICS. Vol. 89, no. 2. (February 1).
  • 2016. Notch signaling in aortic valve development and disease. In Etiology and Morphogenesis of Congenital Heart Disease: From Gene Function and Cellular Interaction to Morphology.
  • 2015. Utilization of Whole-Exome Sequencing to Identify Causative Mutations in Familial Congenital Heart Disease.  CIRCULATION. Vol. 132, no. November 10.
  • Horne TE, VandeKopple M, Sauls K, Koenig SN, Anstine LJ, Garg V, Norris RA, Lincoln J. 2015. Dynamic heterogeneity of the heart valve interstitial cell population in health and disease.”.  J CARDIOVASC DEVELOPMENT DIS. Vol. 2, no. 3. (August): 214-232.
  • Horne TE, VandeKopple M, Sauls K, Koenig SN, Anstine LJ, Garg V, Norris RA, Lincoln J. 2015. Dynamic heterogeneity of the heart valve interstitial cell population in health and disease.”.  J CARDIOVASC DEVELOPMENT DIS. Vol. 2, no. 3. (August 1): 214-232-214-232.
  • Backes CH, Huang H, Cua C, Garg V, Galantowicz M, Bauer JA, Hoffman TH. 2015. Umbilical Cord Clamping in Infants with Congenital Heart Disease.  J PERINATOLOGY. Vol. 35, no. 10. (July): 826-31.
  • Backes CH, Huang H, Cua C, Garg V, Galantowicz M, Bauer JA, Hoffman TH. 2015. Umbilical Cord Clamping in Infants with Congenital Heart Disease.  J PERINATOLOGY. Vol. 35, no. 10. (July 1): 826-31-826-31.
  • Hinton RB, McBride KL, Bleyl SB, Bowles NE, Border WL, Garg V, Smolarek TA, Lalani SR, Ware SM. 2015. Rationale for the Cytogenetic of Cardiovascular Malformations Consortium: a Phenotype Intensive Registry Based Approach.  J CARDIOVASC DEVELOPMENT DIS. Vol. 2, no. 2. (May 1): 76-92-76-92.
  • Hinton RB, McBride KL, Bleyl SB, Bowles NE, Border WL, Garg V, Smolarek TA, Lalani SR, Ware SM. 2015. Rationale for the Cytogenetic of Cardiovascular Malformations Consortium: a Phenotype Intensive Registry Based Approach.  J CARDIOVASC DEVELOPMENT DIS. Vol. 2, no. 2. (May): 76-92.
  • Fitzgerald-Butt S, Bodine A, Klima J, Fry KM, Ash J, Zaidi AN, Garg V, Gerhardt CA, McBride KL. 2015. Measuring Genetic Knowledge: Validation of a Brief Survey Instrument for Adolescents and Adults.  CLIN GENET. Vol. doi:, no. May: e10.1111/cge.12618.
  • Fry, KM, Gerhardt, CA, Ash, J, Zaidi, AN, Garg, V, McBride, KL, Fitzgerald Butt, S,. 2015. Rates of Sexual Debut and Contraception Use among Adolescents and Young Adults with Congenital Heart Disease.  J Adol Health. Vol. 56, no. 4. (April): 396-401.
  • Koenig, SN, Bosse K, Nadorlik HA, Lilly B, Garg V. 2015. Mouse model for bicuspid aortic valve-associated ascending aortic aneurysms.  J CARDIOVASC DEVELOPMENT DIS. Vol. 2, no. 1. (April): 17-30.
  • Fry, KM, Gerhardt, CA, Ash, J, Zaidi, AN, Garg, V, McBride, KL, Fitzgerald Butt, S,. 2015. Rates of Sexual Debut and Contraception Use among Adolescents and Young Adults with Congenital Heart Disease.  J Adol Health. Vol. 56, no. 4. (April 1): 396-401-396-401.
  • Koenig, SN, Bosse K, Nadorlik HA, Lilly B, Garg V. 2015. Mouse model for bicuspid aortic valve-associated ascending aortic aneurysms.  J CARDIOVASC DEVELOPMENT DIS. Vol. 2, no. 1. (April 1): 17-30-17-30.
  • 2015. Lifetime Prevalence of Sexual Intercourse and Contraception Use at Last Sex Among Adolescents and Young Adults With Congenital Heart Disease.  JOURNAL OF ADOLESCENT HEALTH. Vol. 56, no. 4. (April 1).
  • Fry,Kevin,M; Gerhardt,Cynthia,A; Ash,Jerry; Zaidi,Ali,N; Garg,Vidu; McBride,Kim,L; Fitzgerald-Butt,Sara,M. 2015. Lifetime Prevalence of Sexual Intercourse and Contraception Use at Last Sex Among Adolescents and Young Adults With Congenital Heart Disease.  JOURNAL OF ADOLESCENT HEALTH. Vol. 56, no. 4. (April): 396-401.
  • Zhao, N, Koenig, SN, Trask, AJ, Lin, CH, Hans, CP, Lucchesi, PA, Garg, V, Lilly, B. 2015. miR-145 regulates TGFBR2 expression and matrix synthesis in vascular smooth muscle cells.  CIRCULATION RESEARCH. Vol. 116, no. January: 23-24.
  • Zhao, N, Koenig, SN, Trask, AJ, Lin, CH, Hans, CP, Lucchesi, PA, Garg, V, Lilly, B. 2015. miR-145 regulates TGFBR2 expression and matrix synthesis in vascular smooth muscle cells.  CIRCULATION RESEARCH. Vol. 116, no. January 1: 23-24-23-24.
  • Cheng,Jeeyun; Koenig,Sara,N; Kuivaniemi,Helena,S; Garg,Vidu; Hans,Chetan,P. 2014. Pharmacological Inhibitor of Notch Signaling Stabilizes the Progression of Small Abdominal Aortic Aneurysm in a Mouse Model.  JOURNAL OF THE AMERICAN HEART ASSOCIATION. Vol. 3, no. 6. (December): ee001064.
  • 2014. Pharmacological Inhibitor of Notch Signaling Stabilizes the Progression of Small Abdominal Aortic Aneurysm in a Mouse Model.  JOURNAL OF THE AMERICAN HEART ASSOCIATION. Vol. 3, no. 6. (December 1).
  • Misra,Chaitali; Chang,Sheng-Wei; Basu,Madhumita; Huang,Nianyuan; Garg,Vidu. 2014. Disruption of myocardial Gata4 and Tbx5 results in defects in cardiomyocyte proliferation and atrioventricular septation.  HUMAN MOLECULAR GENETICS. Vol. 23, no. 19. (October): 5025-5035.
  • 2014. Disruption of myocardial Gata4 and Tbx5 results in defects in cardiomyocyte proliferation and atrioventricular septation.  HUMAN MOLECULAR GENETICS. Vol. 23, no. 19. (October 1).
  • 2014. Use of a targeted, combinatorial next-generation sequencing approach for the study of bicuspid aortic valve.  BMC MEDICAL GENOMICS. Vol. 7, no. September 26.
  • Bonachea,Elizabeth,M; Zender,Gloria; White,Peter; Corsmeier,Don; Newsom,David; Fitzgerald-Butt,Sara; Garg,Vidu; McBride,Kim,L. 2014. Use of a targeted, combinatorial next-generation sequencing approach for the study of bicuspid aortic valve.  BMC MEDICAL GENOMICS. Vol. 7, no. September: e56.
  • Lincoln,Joy; Garg,Vidu. 2014. Etiology of Valvular Heart Disease - Genetic and Developmental Origins.  CIRCULATION JOURNAL. Vol. 78, no. 8. (August 1): 1801-1807-1801-1807.
  • Lincoln,Joy; Garg,Vidu. 2014. Etiology of Valvular Heart Disease - Genetic and Developmental Origins.  CIRCULATION JOURNAL. Vol. 78, no. 8. (August): 1801-1807.
  • 2014. Rare GATA5 sequence variants identified in individuals with bicuspid aortic valve.  PEDIATRIC RESEARCH. Vol. 76, no. 2. (August 1).
  • Bonachea,Elizabeth,M; Chang,Sheng-Wei; Zender,Gloria; Lahaye,Stephanie; Fitzgerald-Butt,Sara; McBride,Kim,L; Garg,Vidu. 2014. Rare GATA5 sequence variants identified in individuals with bicuspid aortic valve.  PEDIATRIC RESEARCH. Vol. 76, no. 2. (August): 211-216.
  • Hu,Hao; Roach,Jared,C; Coon,Hilary; Guthery,Stephen,L; Voelkerding,Karl,V; Margraf,Rebecca,L; Durtschi,Jacob,D; Tavtigian,Sean,V; Shankaracharya,; Wu,Wilfred; Scheet,Paul; Wang,Shuoguo; Xing,Jinchuan; Glusman,Gustavo; Hubley,Robert; Li,Hong; Garg,Vidu; Moore,Barry; Hood,Leroy; Galas,David,J; Srivastava,Deepak; Reese,Martin,G; Jorde,Lynn,B; Yandell,Mark; Huff,Chad,D. 2014. A unified test of linkage analysis and rare-variant association for analysis of pedigree sequence data.  NATURE BIOTECHNOLOGY. Vol. 32, no. 7. (July): 663-?.
  • 2014. A unified test of linkage analysis and rare-variant association for analysis of pedigree sequence data.  NATURE BIOTECHNOLOGY. Vol. 32, no. 7. (July 1).
  • LaHaye,Stephanie; Lincoln,Joy; Garg,Vidu. 2014. Genetics of valvular heart disease.  CURRENT CARDIOLOGY REPORTS. Vol. 16, no. 6. (June): 487-?.
  • LaHaye,Stephanie; Lincoln,Joy; Garg,Vidu. 2014. Genetics of valvular heart disease.  CURRENT CARDIOLOGY REPORTS. Vol. 16, no. 6. (June 1): 487-?-487-?.
  • Garg,Vidu; Basu,Madhumita. 2014. Beyond genetics: focusing on maternal environment for congenital heart disease prevention.  EVIDENCE-BASED MEDICINE. Vol. 19, no. 2. (April): ee8.
  • 2014. Cohort study: Beyond genetics: Focusing on maternal environment for congenital heart disease prevention.  Evidence-Based Medicine. Vol. 19, no. 2. (January 1).
  • 2014. A mouse model for bicuspid aortic valve-associated ascending aneurysms.  ANGIOGENESIS. Vol. 17, no. 1. (January 1).
  • Lincoln,Joy; Garg,Vidu. 2014. Etiology of valvular heart disease.  Circulation journal. Vol. 78, no. 8. (January 1): 1801-1807-1801-1807.
  • 2014. Modeling smooth muscle vascular disease by direct reprogramming of patient-specific dermal fibroblasts.  ANGIOGENESIS. Vol. 17, no. 1. (January 1).
  • Lincoln,Joy; Garg,Vidu. 2014. Etiology of valvular heart disease.  Circulation journal. Vol. 78, no. 8. (January): 1801-1807.
  • Chang SW, Mislankar M, Misra C, Huang N, Dajusta DG, Harrison SM, McBride KL, Baker LA, Garg V. 2013. Genetic Abnormalities in FOXP1 Are Associated with Congenital Heart Defects.  HUMAN MUTATION. Vol. 34, no. 9. (September 1): 1226-30-1226-30.
  • 2013. Genetic Abnormalities in FOXP1 Are Associated with Congenital Heart Defects.  HUMAN MUTATION. Vol. 34, no. 9. (September 1).
  • Chang SW, Mislankar M, Misra C, Huang N, Dajusta DG, Harrison SM, McBride KL, Baker LA, Garg V. 2013. Genetic Abnormalities in FOXP1 Are Associated with Congenital Heart Defects.  HUMAN MUTATION. Vol. 34, no. 9. (September): 1226-30.
  • Chang,Sheng-Wei; Mislankar,Mona; Misra,Chaitali; Huang,Nianyuan; DaJusta,Daniel,G; Harrison,Steven,M; McBride,Kim,L; Baker,Linda,A; Garg,Vidu. 2013. Genetic Abnormalities in FOXP1 Are Associated with Congenital Heart Defects.  HUMAN MUTATION. Vol. 34, no. 9. (September): 1226-1230.
  • 2013. Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease.  JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. Vol. 60, no. July 1.
  • Bosse K, Hans CP, Zhao N, Koenig SN, Huang N, Guggilam A, Lahaye S, Tao G, Lucchesi PA, Lincoln J, Lilly B, Garg V. 2013. Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease.  J MOL CELL CARDIOL. Vol. 60, no. July: 27-35.
  • Bosse K, Hans CP, Zhao N, Koenig SN, Huang N, Guggilam A, Lahaye S, Tao G, Lucchesi PA, Lincoln J, Lilly B, Garg V. 2013. Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease.  J MOL CELL CARDIOL. Vol. 60, no. July 1: 27-35-27-35.
  • 2013. The Congenital Heart Disease Genetic Network Study Rationale, Design, and Early Results.  CIRCULATION RESEARCH. Vol. 112, no. 4. (February 15).
  • Pediatric Cardiac Genomics Consortium, et al. 2013. The Congenital Heart Disease Genetic Network Study: rationale, design, and early results.  CIRC RES. Vol. 112, no. 4. (February 1): 698-706-698-706.
  • Pediatric Cardiac Genomics Consortium, et al. 2013. The Congenital Heart Disease Genetic Network Study: rationale, design, and early results.  CIRC RES. Vol. 112, no. 4. (February): 698-706.
  • Gelb,Bruce; Brueckner,Martina; Chung,Wendy; Goldmuntz,Elizabeth; Kaltman,Jonathan; Kaski,Juan,Pablo; Kim,Richard; Kline,Jennie; Mercer-Rosa,Laura; Porter,George; Roberts,Amy; Rosenberg,Ellen; Seiden,Howard; Seidman,Christine; Sleeper,Lynn; Tennstedt,Sharon; Kaltman,Jonathan; Schramm,Charlene; Burns,Kristin; Pearson,Gail; Rosenberg,Ellen; Newburger,Jane; Breitbart,Roger; Colan,Steven; Geva,Judith; Monafo,Angela; Roberts,Amy; Stryker,Janice; Seidman,Christine; McDonough,Barbara; Seidman,Jonathan; Goldmuntz,Elizabeth; Edman,Sharon; Garbarini,Jennifer; Hakonarson,Hakon; Mercer-Rosa,Laura; Mitchell,Laura; Tusi,Jessica; White,Peter; Woyciechowski,Stacy; Chung,Wendy; Warburton,Dorothy; Awad,Danielle; Celia,Katrina; Etwaru,Davina; Sond,Jaswinder,Kaur; Kline,Jennie; Korsin,Rosalind; Lanz,Alyssa; Marquez,Emma; Williams,Ismee; Wilpers,Abigail; Yee,Roslyn; Guevara,Denise; Julian,Ariel; Mac Neal,Meghan; Mintz,Cassie; Peter,Inga; Sachidanandam,Ravi; Seiden,Howard; Romano-Adesman,Angela; Gruber,Dorota; Stellato,Nancy; Brueckner,Martina; Lifton,Richard; Cross,Nancy; Deanfield,John; Giardini,Alessandro; Flack,Karen; Porter,George; Taillie,Eileen; Kim,Richard; Nhu Tran,N; Tennstedt,Sharon; Breitbart,Roger; Dandreo,Kimberly; Gallagher,Dianne; Lu,Minmin; Sleeper,Lynn; Berlin,Dorit; Beiswanger,Christine; Lifton,Richard; Seidman,Jonathan; Hakonarson,Hakon; White,Peter; Italia,Mike; Chung,Wendy; Seidman,Christine; Brooks,Maria; Olive,Michelle; Botkin,Jeffrey; Dupuis,Josee; Garg,Vidu; Watson,Mike; Bristow,James; Evans,Todd; Kendziorski,Christina; Mardis,Elaine; Murray,Jeffrey; Saltz,Joel; Wong,Hector. 2013. The Congenital Heart Disease Genetic Network Study Rationale, Design, and Early Results.  CIRCULATION RESEARCH. Vol. 112, no. 4. (February): 698-706.
  • 2013. Compacting the heart with Notch.  NATURE MEDICINE. Vol. 19, no. 2. (February 1).
  • Misra,Chaitali; Garg,Vidu. 2013. Compacting the heart with Notch.  NATURE MEDICINE. Vol. 19, no. 2. (February): 133-134.
  • Hans,Chetan,P; Koenig,Sara,N; Huang,Nianyuan; Cheng,Jeeyun; Beceiro,Susana; Guggilam,Anuradha; Kuivaniemi,Helena; Partida-Sanchez,Santiago; Garg,Vidu. 2012. Inhibition of Notch1 Signaling Reduces Abdominal Aortic Aneurysm in Mice by Attenuating Macrophage-Mediated Inflammation.  ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. Vol. 32, no. 12. (December): 3012-23.
  • 2012. Notch Inhibition Prevents the Progression of Small Abdominal Aortic Aneurysms in AngII-Induced Mouse Model.  CIRCULATION RESEARCH. Vol. 111, no. 12. (December 1).
  • 2012. Inhibition of Notch1 Signaling Reduces Abdominal Aortic Aneurysm in Mice by Attenuating Macrophage-Mediated Inflammation.  ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. Vol. 32, no. 12. (December 1).
  • Garg, V. 2012. The Molecular Basis of Cardiac Development and Congenital Heart Disease. In Translational Cardiology. Edited by Patterson C and Willis MS.
  • Garg, V. 2012. The Molecular Basis of Cardiac Development and Congenital Heart Disease. In Translational Cardiology. Edited by Patterson C and Willis MS. New York: Springer-Humana Press.
  • Payne,Ashleigh,R; Chang,Sheng-Wei; Koenig,Sara,N; Zinn,Andrew,R; Garg,Vidu. 2012. Submicroscopic Chromosomal Copy Number Variations Identified in Children With Hypoplastic Left Heart Syndrome.  PEDIATRIC CARDIOLOGY. Vol. 33, no. 5. (June): 757-763.
  • 2012. Submicroscopic Chromosomal Copy Number Variations Identified in Children With Hypoplastic Left Heart Syndrome.  PEDIATRIC CARDIOLOGY. Vol. 33, no. 5. (June 1).
  • 2012. Congenital Heart Disease-Causing Gata4 Mutation Displays Functional Deficits In Vivo.  PLOS GENETICS. Vol. 8, no. 5. (May 1).
  • Misra,Chaitali; Sachan,Nita; McNally,Caryn,Rothrock; Koenig,Sara,N; Nichols,Haley,A; Guggilam,Anuradha; Lucchesi,Pamela,A; Pu,William,T; Srivastava,Deepak; Garg,Vidu. 2012. Congenital heart disease-causing gata4 mutation displays functional deficits in vivo.  PLoS GENETICS. Vol. 8, no. 5. (May): ee1002690.
  • Bhoj,Elizabeth,J; Ramos,Purita; Baker,Linda,A; Garg,Vidu; Cost,Nicholas; Nordenskjoeld,Agneta; Elder,Frederick,F; Bleyl,Steven,B; Bowles,Neil,E; Arrington,Cammon,B; Delhomme,Brigitte; Vanhoutteghem,Amandine; Djian,Philippe; Zinn,Andrew,R. 2012. Human balanced translocation and mouse gene inactivation implicate Basonuclin 2 in distal urethral development (vol 20, pg 249, 2012).  EUROPEAN JOURNAL OF HUMAN GENETICS. Vol. 20, no. 2. (February): 249-249.
  • 2012. Human balanced translocation and mouse gene inactivation implicate Basonuclin 2 in distal urethral development (vol 20, pg 249, 2012).  EUROPEAN JOURNAL OF HUMAN GENETICS. Vol. 20, no. 2. (February 1).
  • Garg, V. 2011. Growth of the Normal Human Heart. In Handbook of Growth and Growth Monitoring in Health and Disease. Edited by Victor R. Preedy. New York: Springer.
  • Garg, V. 2011. Growth of the Normal Human Heart. In Handbook of Growth and Growth Monitoring in Health and Disease. Edited by Preedy, VR.
  • Garg, V. 2011. Growth of the Normal Human Heart. In Handbook of Growth and Growth Monitoring in Health and Disease. Edited by Preedy, VR. New York: Springer.
  • 2011. Inhibition of Notch Reduces Incidence of Aortic Abdominal Aneurysm by Preventing Macrophage-Mediated Inflammation.  CIRCULATION. Vol. 124, no. 21. (November 22).
  • 2011. Inhibitory Role of Notch1 in Calcific Aortic Valve Disease.  PLOS ONE. Vol. 6, no. 11. (November 16).
  • Acharya,Asha; Hans,Chetan,P; Koenig,Sara,N; Nichols,Haley,A; Galindo,Cristi,L; Garner,Harold,R; Merrill,Walter,H; Hinton,Robert,B; Garg,Vidu. 2011. Inhibitory Role of Notch1 in Calcific Aortic Valve Disease.  PLOS ONE. Vol. 6, no. 11. (November): ee27743.
  • 2011. Chromosomal Haplotypes by Genetic Phasing of Human Families.  AMERICAN JOURNAL OF HUMAN GENETICS. Vol. 89, no. 3. (September 9).
  • Roach,Jared,C; Glusman,Gustavo; Hubley,Robert; Montsaroff,Stephen,Z; Holloway,Alisha,K; Mauldin,Denise,E; Srivastava,Deepak; Garg,Vidu; Pollard,Katherine,S; Galas,David,J; Hood,Leroy; Smit,Arian,FA. 2011. Chromosomal Haplotypes by Genetic Phasing of Human Families.  AMERICAN JOURNAL OF HUMAN GENETICS. Vol. 89, no. 3. (September): 382-397.
  • McBride,Kim,L; Garg,Vidu. 2011. Heredity of bicuspid aortic valve: is family screening indicated?.  HEART. Vol. 97, no. 15. (August): 1193-1195.
  • 2011. Heredity of bicuspid aortic valve: is family screening indicated?.  HEART. Vol. 97, no. 15. (August 1).
  • Acharya A, Hans CP, Koenig SN, Nichols HA, Galindo C, Garner HR, Merrill WH, Hinton RB, Garg, V. 2011. Inhibitory role of Notch1 in calcific aortic valve disease is mediated by Sox9.  PLoS One. Vol. 6, no. 11. (January): ee27743.
  • Acharya A, Hans CP, Koenig SN, Nichols HA, Galindo C, Garner HR, Merrill WH, Hinton RB, Garg, V. 2011. Inhibitory role of Notch1 in calcific aortic valve disease is mediated by Sox9.  PLoS One. Vol. 6, no. 11. (January 1): e27743-e27743.
  • McBride KL and Garg V. 2011. Heredity of Bicuspid Aortic Valve: Is Family Screening Indicated?.  Heart. Vol. 97, no. 15. (January 1): 1193-1195-1193-1195.
  • Roach JC, Glusman G, Hubley R, Montsaroff SZ, Holloway AK, Mauldin DE, Srivastava D, Garg V, Pollard KS, Galas DJ, Hood L, Smit AF. 2011. Chromosomal haplotypes by genetic phasing of human families.  Am J Hum Genet. Vol. 89, no. 3. (January): 382-397.
  • Roach JC, Glusman G, Hubley R, Montsaroff SZ, Holloway AK, Mauldin DE, Srivastava D, Garg V, Pollard KS, Galas DJ, Hood L, Smit AF. 2011. Chromosomal haplotypes by genetic phasing of human families.  Am J Hum Genet. Vol. 89, no. 3. (January 1): 382-397-382-397.
  • McBride KL and Garg V. 2011. Heredity of Bicuspid Aortic Valve: Is Family Screening Indicated?.  Heart. Vol. 97, no. 15. (January): 1193-1195.
  • 2010. Fetal and postnatal lung defects reveal a novel and required role for Fgf8 in lung development.  DEVELOPMENTAL BIOLOGY. Vol. 347, no. 1. (November 1).
  • Yu,Shibin; Poe,Bryan; Schwarz,Margaret; Elliot,Sarah,A; Albertine,Kurt,H; Fenton,Stephen; Garg,Vidu; Moon,Anne,M. 2010. Fetal and postnatal lung defects reveal a novel and required role for Fgf8 in lung development.  DEVELOPMENTAL BIOLOGY. Vol. 347, no. 1. (November): 92-108.
  • Maitra,Meenaksh; Koenig,Sara,N; Srivastava,Deepak; Garg,Vidu. 2010. Identification of GATA6 Sequence Variants in Patients With Congenital Heart Defects.  PEDIATRIC RESEARCH. Vol. 68, no. 4. (October): 281-285.
  • 2010. Identification of GATA6 Sequence Variants in Patients With Congenital Heart Defects.  PEDIATRIC RESEARCH. Vol. 68, no. 4. (October 1).
  • Richards,Ashleigh,A; Garg,Vidu. 2010. Genetics of congenital heart disease.  Current cardiology reviews. Vol. 6, no. 2. (May): 91-97.
  • Richards,Ashleigh,A; Garg,Vidu. 2010. Genetics of congenital heart disease.  CURRENT CARDIOLOGY REVIEWS. Vol. 6, no. 2. (May 1): 91-97-91-97.
  • 2010. Genetics of congenital heart disease.
  • Richards,Ashleigh,A; Garg,Vidu. 2010. Genetics of congenital heart disease.  CURRENT CARDIOLOGY REVIEWS. Vol. 6, no. 2. (May): 91-97.
  • Richards A and Garg V. 2010. Genetics of congenital heart disease.  CURRENT CARDIOLOGY REVIEWS. Vol. 6, no. 2. (May): 91-97.
  • Richards,Ashleigh,A; Garg,Vidu. 2010. Genetics of congenital heart disease.  Current cardiology reviews. Vol. 6, no. 2. (May 1): 91-97-91-97.
  • Richards A and Garg V. 2010. Genetics of congenital heart disease.  CURRENT CARDIOLOGY REVIEWS. Vol. 6, no. 2. (May 1): 91-97-91-97.
  • 2010. Impact of Mendelian inheritance in cardiovascular disease.  YEAR IN HUMAN AND MEDICAL GENETICS: NEW TRENDS IN MENDELIAN GENETICS. Vol. 1214, no. January 1.
  • Richards AA; Garg V. 2010. Genetics of Congenital Heart Disease.  Current Cardiology Reviews. Vol. 6, no. 2. (January 1): 91-97-91-97.
  • Richards AA; Garg V. 2010. Genetics of Congenital Heart Disease.  Current Cardiology Reviews. Vol. 6, no. 2. (January): 91-97.
  • McBride,Kim,L; Garg,Vidu. 2010. Impact of Mendelian inheritance in cardiovascular disease.  ANN N Y ACAD SCI. Vol. 1214, no. January: 122-137.
  • Pan H; Richards AA; Zhu X; Joglar JA; Yin HL; Garg V. 2009. A novel mutation in LAMIN A/C is associated with isolated early-onset atrial fibrillation and progressive atrioventricular block followed by cardiomyopathy and sudden cardiac death.  Heart Rhythm: The Official Journal Of The Heart Rhythm Society. Vol. 6, no. 5. (May 1): 707-707.
  • Pan,Hubert; Richards,Ashleigh,A; Zhu,Xiaohui; Jogtar,Jose,A; Yin,Helen,L; Garg,Vidu. 2009. A novel mutation in LAMIN A/C is associated with isolated early-onset atrial fibrillation and progressive atrioventricular block followed by cardiomyopathy and sudden cardiac death.  HEART RHYTHM. Vol. 6, no. 5. (May): 707-710.
  • Pan H; Richards AA; Zhu X; Joglar JA; Yin HL; Garg V. 2009. A novel mutation in LAMIN A/C is associated with isolated early-onset atrial fibrillation and progressive atrioventricular block followed by cardiomyopathy and sudden cardiac death.  Heart Rhythm: The Official Journal Of The Heart Rhythm Society. Vol. 6, no. 5. (May): e707.
  • 2009. A novel mutation in LAMIN A/C is associated with isolated early-onset atrial fibrillation and progressive atrioventricular block followed by cardiomyopathy and sudden cardiac death.  HEART RHYTHM. Vol. 6, no. 5. (May 1).
  • 2009. EXPRESSION PATTERNS OF BASONUCLIN 2 IN PENILE TISSUE.  JOURNAL OF UROLOGY. Vol. 181, no. 4. (April 1).
  • 2009. Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development.  DEVELOPMENTAL BIOLOGY. Vol. 326, no. 2. (February 15).
  • Maitra,Meenakshi; Schluterman,Marie,K; Nichols,Haley,A; Richardson,James,A; Lo,Cecilia,W; Srivastava,Deepak; Garg,Vidu. 2009. Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development.  DEVELOPMENTAL BIOLOGY. Vol. 326, no. 2. (February): 368-377.
  • Maitra M; Schluterman MK; Nichols HA; Richardson JA; Lo CW; Srivastava D; Garg V. 2009. Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development.  Developmental Biology. Vol. 326, no. 2. (February 1): 368-368.
  • Maitra M; Schluterman MK; Nichols HA; Richardson JA; Lo CW; Srivastava D; Garg V. 2009. Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development.  Developmental Biology. Vol. 326, no. 2. (February): e368.
  • Maitra,Meenakshi; Schluterman,Marie,K; Nichols,Haley,A; Richardson,James,A; Lo,Cecilia,W; Srivastava,Deepak; Garg,Vidu. 2009. Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development.  DEVELOPMENTAL BIOLOGY. Vol. 326, no. 2. (February 1): 368-377-368-377.
  • 2008. A Rare Human Sequence Variant Reveals Myocardin Autoinhibition.  JOURNAL OF BIOLOGICAL CHEMISTRY. Vol. 283, no. 51. (December 19).
  • Ransom JF; King IN; Garg V; Srivastava D. 2008. A rare human sequence variant reveals myocardin autoinhibition.  The Journal Of Biological Chemistry. Vol. 283, no. 51. (December): e35845.
  • Ransom,Joshua,F; King,Isabelle,N; Garg,Vidu; Srivastava,Deepak. 2008. A Rare Human Sequence Variant Reveals Myocardin Autoinhibition.  JOURNAL OF BIOLOGICAL CHEMISTRY. Vol. 283, no. 51. (December): 35845-35852.
  • Ransom JF; King IN; Garg V; Srivastava D. 2008. A rare human sequence variant reveals myocardin autoinhibition.  The Journal Of Biological Chemistry. Vol. 283, no. 51. (December 1): 35845-35845.
  • 2008. The Human GATA4 G296S Mutation Disrupts Mouse Cardiac Morphogenesis.  CIRCULATION. Vol. 118, no. 18. (October 28).
  • Richards,Ashleigh,A; Santos,Lane,Jaeckle; Nichols,Haley,A; Crider,Bill,P; Elder,Frederick,F; Hauser,Natalie,S; Zinn,Andrew,R; Garg,Vidu. 2008. Cryptic chromosomal abnormalities identified in children with congenital heart disease.  PEDIATRIC RESEARCH. Vol. 64, no. 4. (October): 358-363.
  • 2008. Cryptic chromosomal abnormalities identified in children with congenital heart disease.  PEDIATRIC RESEARCH. Vol. 64, no. 4. (October 1).
  • Richards AA; Santos LJ; Nichols HA; Crider BP; Elder FF; Hauser NS; Zinn AR; Garg V. 2008. Cryptic chromosomal abnormalities identified in children with congenital heart disease.  Pediatric Research. Vol. 64, no. 4. (October): e358.
  • Richards AA; Santos LJ; Nichols HA; Crider BP; Elder FF; Hauser NS; Zinn AR; Garg V. 2008. Cryptic chromosomal abnormalities identified in children with congenital heart disease.  Pediatric Research. Vol. 64, no. 4. (October 1): 358-358.
  • Rajagopal SK; Ma Q; Obler D; Shen J; Manichaikul A; Tomita-Mitchell A; Boardman K; Briggs C; Garg V; Srivastava D; Goldmuntz E; Broman KW; Benson DW; Smoot LB; Pu WT. 2007. Spectrum of heart disease associated with murine and human GATA4 mutation.  Journal Of Molecular And Cellular Cardiology. Vol. 43, no. 6. (December): e677.
  • Tomita-Mitchell A; Maslen CL; Morris CD; Garg V; Goldmuntz E. 2007. GATA4 sequence variants in patients with congenital heart disease.  Journal Of Medical Genetics. Vol. 44, no. 12. (December 1): 779-779.
  • Tomita-Mitchell A; Maslen CL; Morris CD; Garg V; Goldmuntz E. 2007. GATA4 sequence variants in patients with congenital heart disease.  Journal Of Medical Genetics. Vol. 44, no. 12. (December): e779.
  • 2007. GATA4 sequence variants in patients with congenital heart disease.  JOURNAL OF MEDICAL GENETICS. Vol. 44, no. 12. (December 1).
  • Rajagopal SK; Ma Q; Obler D; Shen J; Manichaikul A; Tomita-Mitchell A; Boardman K; Briggs C; Garg V; Srivastava D; Goldmuntz E; Broman KW; Benson DW; Smoot LB; Pu WT. 2007. Spectrum of heart disease associated with murine and human GATA4 mutation.  Journal Of Molecular And Cellular Cardiology. Vol. 43, no. 6. (December 1): 677-677.
  • 2007. Spectrum of heart disease associated with murine and human GATA4 mutation.  JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. Vol. 43, no. 6. (December 1).
  • Tomita-Mitchell,A; Maslen,C,L; Morris,C,D; Garg,V; Goldmuntz,E. 2007. GATA4 sequence variants in patients with congenital heart disease.  JOURNAL OF MEDICAL GENETICS. Vol. 44, no. 12. (December): 779-783.
  • Rajagopal,Satish,K; Ma,Qing; Obler,Dita; Shen,Ji; Manichaikul,Am; Tomita-Mitchell,Aoy; Boardman,Kari; Briggs,Christine; Garg,Vidu; Srivastava,Deepak; Goldmuntz,Elizabeth; Broman,Karl,W; Benson,D,Woodrow; Smoot,Leslie,B; Pu,William,T. 2007. Spectrum of heart disease associated with murine and human GATA4 mutation.  JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. Vol. 43, no. 6. (December): 677-685.
  • 2007. Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease.  AMERICAN JOURNAL OF MEDICAL GENETICS PART A. Vol. 143A, no. 8. (April 15).
  • Schluterman,Marie,K; Krysiak,Amanda,E; Kathiriya,Irfan,S; Abate,Nicola; Chandalia,Manisha; Srivastava,Deepak; Garg,Vidu. 2007. Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease.  AMERICAN JOURNAL OF MEDICAL GENETICS PART A. Vol. 143A, no. 8. (April): 817-823.
  • Schluterman MK; Krysiak AE; Kathiriya IS; Abate N; Chandalia M; Srivastava D; Garg V. 2007. Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease.  American Journal Of Medical Genetics. Part A. Vol. 143A, no. 8. (April 1): 817-817.
  • Schluterman MK; Krysiak AE; Kathiriya IS; Abate N; Chandalia M; Srivastava D; Garg V. 2007. Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease.  American Journal Of Medical Genetics. Part A. Vol. 143A, no. 8. (April): e817.
  • Garg,V. 2006. Insights into the genetic basis of congenital heart disease.  CELLULAR AND MOLECULAR LIFE SCIENCES. Vol. 63, no. 10. (May): 1141-1148.
  • 2006. Insights into the genetic basis of congenital heart disease.  CELLULAR AND MOLECULAR LIFE SCIENCES. Vol. 63, no. 10. (May 1).
  • Garg,Vidu. 2006. Molecular genetics of aortic valve disease.  CURRENT OPINION IN CARDIOLOGY. Vol. 21, no. 3. (May): 180-184.
  • Garg V. 2006. Molecular genetics of aortic valve disease.  Current Opinion In Cardiology. Vol. 21, no. 3. (May 1): 180-180.
  • 2006. Molecular genetics of aortic valve disease.  CURRENT OPINION IN CARDIOLOGY. Vol. 21, no. 3. (May 1).
  • Garg V. 2006. Molecular genetics of aortic valve disease.  Current Opinion In Cardiology. Vol. 21, no. 3. (May): e180.
  • Garg V. 2006. Insights into the genetic basis of congenital heart disease.  Cellular And Molecular Life Sciences: CMLS. Vol. 63, no. 10. (May 1): 1141-1141.
  • Garg V. 2006. Insights into the genetic basis of congenital heart disease.  Cellular And Molecular Life Sciences: CMLS. Vol. 63, no. 10. (May): e1141.
  • 2005. Mutations in NOTCH1 cause aortic valve disease.  NATURE. Vol. 437, no. 7056. (September 8).
  • Garg V; Muth AN; Ransom JF; Schluterman MK; Barnes R; King IN; Grossfeld PD; Srivastava D. 2005. Mutations in NOTCH1 cause aortic valve disease.  Nature. Vol. 437, no. 7056. (September 1): 270-270.
  • Garg,V; Muth,A,N; Ransom,J,F; Schluterman,M,K; Barnes,R; King,I,N; Grossfeld,P,D; Srivastava,D. 2005. Mutations in NOTCH1 cause aortic valve disease.  NATURE. Vol. 437, no. 7056. (September): 270-274.
  • Garg V; Muth AN; Ransom JF; Schluterman MK; Barnes R; King IN; Grossfeld PD; Srivastava D. 2005. Mutations in NOTCH1 cause aortic valve disease.  Nature. Vol. 437, no. 7056. (September): e270.
  • Garg, V. and Srivastava, D. 2005. Genetic Underpinnings of Cardiogenesis and Congenital Heart Disease. In Principles of Molecular Cardiology. Edited by C. Patterson and M. Runge.
  • Garg, V. and Srivastava, D. 2005. Genetic Underpinnings of Cardiogenesis and Congenital Heart Disease. In Principles of Molecular Cardiology. Edited by C. Patterson and M. Runge. New York: Springer-Verlag.
  • 2003. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5.  NATURE. Vol. 424, no. 6947. (July 24).
  • Garg V; Kathiriya IS; Barnes R; Schluterman MK; King IN; Butler CA; Rothrock CR; Eapen RS; Hirayama-Yamada K; Joo K; Matsuoka R; Cohen JC; Srivastava D. 2003. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5.  Nature. Vol. 424, no. 6947. (July 1): 443-443.
  • Garg V; Kathiriya IS; Barnes R; Schluterman MK; King IN; Butler CA; Rothrock CR; Eapen RS; Hirayama-Yamada K; Joo K; Matsuoka R; Cohen JC; Srivastava D. 2003. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5.  Nature. Vol. 424, no. 6947. (July): e443.
  • Garg,V; Kathiriyra,I,S; Barnes,R; Schluterman,M,K; King,I,N; Butler,C,A; Rothrock,C,R; Eapen,R,S; Hirayama-Yamada,K; Joo,K; Matsuoka,R; Cohen,J,C; Srivastava,D. 2003. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5.  NATURE. Vol. 424, no. 6947. (July 1): 443-447-443-447.
  • Garg,V; Kathiriyra,I,S; Barnes,R; Schluterman,M,K; King,I,N; Butler,C,A; Rothrock,C,R; Eapen,R,S; Hirayama-Yamada,K; Joo,K; Matsuoka,R; Cohen,J,C; Srivastava,D. 2003. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5.  NATURE. Vol. 424, no. 6947. (July): 443-447.
  • Garg V; Srivastava D. 2002. Cardiac Development and congenital heart disease. In American College of Cardiology Self Assessment Program V. Edited by Fishman, M.
  • Garg V; Srivastava D. 2002. Cardiac Development and congenital heart disease. In American College of Cardiology Self Assessment Program V. Edited by Fishman, M. Bethesda: American College of Cardiology.
  • 2001. A common cis-acting sequence in the DiGeorge critical region regulates bi-directional transcription of UFD1L and CDC45L.  MECHANISMS OF DEVELOPMENT. Vol. 108, no. 1-2. (October 1).
  • Kunte A; Ivey K; Yamagishi C; Garg V; Yamagishi H; Srivastava D. 2001. A common cis-acting sequence in the DiGeorge critical region regulates bi-directional transcription of UFD1L and CDC45L.  Mechanisms Of Development. Vol. 108, no. 1-2. (October 1): 81-81.
  • Kunte A; Ivey K; Yamagishi C; Garg V; Yamagishi H; Srivastava D. 2001. A common cis-acting sequence in the DiGeorge critical region regulates bi-directional transcription of UFD1L and CDC45L.  Mechanisms Of Development. Vol. 108, no. 1-2. (October): e81.
  • Kunte,A; Ivey,K; Yamagishi,C; Garg,V; Yamagishi,H; Srivastava,D. 2001. A common cis-acting sequence in the DiGeorge critical region regulates bi-directional transcription of UFD1L and CDC45L.  MECHANISMS OF DEVELOPMENT. Vol. 108, no. 1-2. (October): 81-92.
  • Garg V; Yamagishi C; Hu T; Kathiriya IS; Yamagishi H; Srivastava D. 2001. Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog during pharyngeal arch development.  Developmental Biology. Vol. 235, no. 1. (July 1): 62-62.
  • Garg,V; Yamagishi,C; Hu,T,H; Kathiriya,I,S; Yamagishi,H; Srivastava,D. 2001. Tbx1, a DiGeorge syndrome candidate gene, is regulated by Sonic hedgehog during pharyngeal arch development.  DEVELOPMENTAL BIOLOGY. Vol. 235, no. 1. (July 1): 62-73-62-73.
  • Garg V; Yamagishi C; Hu T; Kathiriya IS; Yamagishi H; Srivastava D. 2001. Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog during pharyngeal arch development.  Developmental Biology. Vol. 235, no. 1. (July): e62.
  • Garg,V; Yamagishi,C; Hu,T,H; Kathiriya,I,S; Yamagishi,H; Srivastava,D. 2001. Tbx1, a DiGeorge syndrome candidate gene, is regulated by Sonic hedgehog during pharyngeal arch development.  DEVELOPMENTAL BIOLOGY. Vol. 235, no. 1. (July): 62-73.
  • 2001. Tbx1, a DiGeorge syndrome candidate gene, is regulated by Sonic hedgehog during pharyngeal arch development.  DEVELOPMENTAL BIOLOGY. Vol. 235, no. 1. (July 1).
  • Garg V; Srivastava D. 2001. 22q11 deletion syndrome.  Pediatric Society of Greater Dallas Newsletter.
  • Garg V; Srivastava D. 2001. 22q11 deletion syndrome.  Pediatric Society of Greater Dallas Newsletter.
  • Srivastava D; Garg V. 2001. Potential for fetal gene therapy in congenital heart disease.  FRONTIERS IN FETAL HEALTH. Vol. 3, no. 7. (January): 211-212.
  • Srivastava D; Garg V. 2001. Potential for fetal gene therapy in congenital heart disease.  FRONTIERS IN FETAL HEALTH. Vol. 3, no. 7. (January 1): 211-212-211-212.
  • 1999. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects.  SCIENCE. Vol. 283, no. 5405. (February 19).
  • Yamagishi H; Garg V; Matsuoka R; Thomas T; Srivastava D. 1999. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects.  Science (New York, N.Y.). Vol. 283, no. 5405. (February 1): 1158-1158.
  • Yamagishi,H; Garg,V; Matsuoka,R; Thomas,T; Srivastava,D. 1999. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects.  SCIENCE. Vol. 283, no. 5405. (February): 1158-1161.
  • Yamagishi H; Garg V; Matsuoka R; Thomas T; Srivastava D. 1999. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects.  Science (New York, N.Y.). Vol. 283, no. 5405. (February): e1158.
  • LaHaye S, Corsemeier D, Bowman JL, Fitzgerald-Butt S, Zender G, Bosse K, McBride KL, White P and Garg V. Utilization of Whole-Exome Sequencing to Identify Causative Mutations in Familial Congenital Heart Disease.  Circulation.
  • Backes CH, Huang H, Cua C, Garg V, Galantowicz M, Bauer JA, Hoffman TH. Umbilical Cord Clamping in Infants with Congenital Heart Disease.  J PERINATOLOGY.
  • Hinton RB, McBride KL, Bleyl SB, Bowles NE, Border WL, Garg V, Smolarek TA, Lalani SR, Ware SM. Rationale for the Cytogenetic of Cardiovascular Malformations Consortium: a Phenotype Intensive Registry Based Approach.  J Cardiovasc Development Dis.
  • Fitzgerald-Butt S, Bodine A, Klima J, Fry KM, Ash J, Zaidi AN, Garg V, Gerhardt CA, McBride KL. Measuring Genetic Knowledge: Validation of a Brief Survey Instrument for Adolescents and Adults.  CLIN GENET.
  • LaHaye S, Corsemeier D, Bowman JL, Fitzgerald-Butt S, Zender G, Bosse K, McBride KL, White P and Garg V. Utilization of Whole-Exome Sequencing to Identify Causative Mutations in Familial Congenital Heart Disease.  Circulation.
  • Hinton RB, McBride KL, Bleyl SB, Bowles NE, Border WL, Garg V, Smolarek TA, Lalani SR, Ware SM. Rationale for the Cytogenetic of Cardiovascular Malformations Consortium: a Phenotype Intensive Registry Based Approach.  J Cardiovasc Development Dis.
  • Garg V and Basu M. Beyond Genetics: focusing on maternal environment for congenital heart disease prevention.  Evidence Based Medicine.
  • Fitzgerald-Butt S, Bodine A, Klima J, Fry KM, Ash J, Zaidi AN, Garg V, Gerhardt CA, McBride KL. Measuring Genetic Knowledge: Validation of a Brief Survey Instrument for Adolescents and Adults.  CLIN GENET.
  • Chang SW, Mislankar M, Misra C, Huang N, Dajusta DG, Harrison SM, McBride KL, Baker LA, Garg V. Genetic abnormalities in FOXP1 are associated with congenital heart defects.  HUMAN MUTATION.
  • Backes CH, Huang H, Cua C, Garg V, Galantowicz M, Bauer JA, Hoffman TH. Umbilical Cord Clamping in Infants with Congenital Heart Disease.  J PERINATOLOGY.
  • Chang SW, Mislankar M, Misra C, Huang N, Dajusta DG, Harrison SM, McBride KL, Baker LA, Garg V. Genetic abnormalities in FOXP1 are associated with congenital heart defects.  HUMAN MUTATION.

featured video

Meet Vidu Garg, MD, Director of Translational Research at The Heart Center and Director of the Center for Cardiovascular Research at The Research Institute at Nationwide Children’s Hospital.
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000